David Sinclair· PhD
Declining NAD levels as an inherent and targetable risk factor for Alzheimer’s disease
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
Declining NAD levels as an inherent and targetable risk factor for Alzheimer’s disease
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Brain NAD+ levels decline precipitously with age, especially in Alzheimer's.
Severity of Alzheimer’s disease (AD) correlates with NAD+ homeostasis dysregulation
Preserving brain NAD+ homeostasis prevents AD in mice